|3月27日(0-24时)上海新增50例本土新冠肺炎确诊病例,新增3450例本土无症状感染者,新增10例境外输入病例-MedSci.cn - 风湿免疫
Baidu
map

情况通报|3月27日(0-24时)上海新增50例本土新冠肺炎确诊病例,新增3450例本土无症状感染者,新增10例境外输入病例

2022-03-28 上海发布 网络

上海市卫健委发布本市情况通报

市卫健委今早(28日)通报:2022年3月27日0—24时,新增本土新冠肺炎确诊病例50例和无症状感染者3450例,其中17例确诊病例和2833例无症状感染者在隔离管控中发现,其余在相关风险人群排查中发现。新增境外输入性新冠肺炎确诊病例10例和无症状感染者4例,均在闭环管控中发现。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1949056, encodeId=6bad19490569b, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Thu Feb 09 22:03:17 CST 2023, time=2023-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353329, encodeId=8f10135332962, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 02:03:17 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485255, encodeId=88b91485255b3, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Wed Mar 30 02:03:17 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1949056, encodeId=6bad19490569b, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Thu Feb 09 22:03:17 CST 2023, time=2023-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353329, encodeId=8f10135332962, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 02:03:17 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485255, encodeId=88b91485255b3, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Wed Mar 30 02:03:17 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1949056, encodeId=6bad19490569b, content=<a href='/topic/show?id=311793e585f' target=_blank style='color:#2F92EE;'>#输入病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93758, encryptionId=311793e585f, topicName=输入病例)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Thu Feb 09 22:03:17 CST 2023, time=2023-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353329, encodeId=8f10135332962, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Mar 30 02:03:17 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485255, encodeId=88b91485255b3, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Wed Mar 30 02:03:17 CST 2022, time=2022-03-30, status=1, ipAttribution=)]

相关资讯

首次!武汉大学研发新冠病毒快检新方法,检出率达94.2%

武汉大学开发出了一种高灵敏度、高特异性、操作便捷且快速的核酸检测方法。

2022年3月28日河北疫情全新消息:河北新增本土病例7+144,其中唐山2+108

截至3月27日24时,河北省现有本土确诊病例349例。

昨日新增本土“2281+2313”:3月22日新冠疫情情况通报

据3月22日通报,全国现有确诊病例23138例,其中重症病例42例。

国家卫健委印发《区域新型冠状病毒核酸检测组织实施指南(第三版)》

在精准快速的流调排查、社区管控基础上,科学研判疫情传播风险,划定区域核酸检测范围,制定具体工作方案,加强组织管理,优化采、送、检、报流程,进一步提升核酸检测质量和效率。

快讯|上海市核酸筛查区域交通管制通告

上海发布就疫情期间交通管制问题发布权威通告。

NEJM:接种第三针BNT162b2疫苗预防新冠肺炎感染的有效性高达95.3%

在完成第二针 BNT162b2疫苗接种后10个月,接种第三针后疫苗预防感染的有效性达到95.3%,未发生新的安全事件。

Baidu
map
Baidu
map
Baidu
map